Neogene Therapeutics is now a part of the AstraZeneca Group. Visit AstraZeneca.com. AstraZeneca.com ...

Engineering TGF-β-resistant TCR-edited T cells for mutant TP53-targeted cancer immunotherapy Vanessa Tubb, Sander Eshuis, Paula Kroon, Xiangjun Kong, Ton N.M. Schumacher,

Neogene T-Cell Processing. Sign in with Neogene Sign in with AstraZeneca

Dr. Perez Garcia is the Vice President of Translational Sciences at Neogene Therapeutics. She has more than 16 years of combined academic and biopharma industry experience in cancer …

Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumors SANTA MONICA, Calif., and AMSTERDAM, November 28, 2022 – …

Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumors SANTA MONICA, Calif., and AMSTERDAM, November 28, 2022 – …

Neogene Therapeutics, Inc. 2225 Colorado Ave Santa Monica, CA 90404 United States

Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies

Pushing the frontier by pioneering a new class of fully personalized T cell therapies to treat cancer